An Open-Label Study of the Safety and Efficacy of ReFacto AF in Previously Untreated Patients in Usual Care Settings Estudio abierto sobre seguridad y eficacia de ReFacto AF en pacientes no tratados p...

Update Il y a 4 ans
Reference: EUCTR2008-008436-93

An Open-Label Study of the Safety and Efficacy of ReFacto AF in Previously Untreated Patients in Usual Care Settings Estudio abierto sobre seguridad y eficacia de ReFacto AF en pacientes no tratados previamente, en condiciones asistenciales habituales

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to evaluate the safety of ReFacto AF in previously untreated patients less than 6 years of age.


Inclusion criteria

  • Severe hemophilia A (FVIII:C <1%) in male subjects <6 years of age. Hemofilia A severa (FVIII:C<1%) en sujetos pediátricos menores de seis años de edad